|
TRMT12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94300131539649E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46094247810424E-12 |
| Normal-vs-Stage2 |
2.06759999998862E-06 |
| Normal-vs-Stage3 |
2.17680000025311E-07 |
| Normal-vs-Stage4 |
1.198520E-03 |
| Stage1-vs-Stage2 |
5.955000E-01 |
| Stage1-vs-Stage3 |
9.857200E-01 |
| Stage1-vs-Stage4 |
4.689800E-01 |
| Stage2-vs-Stage3 |
6.035200E-01 |
| Stage2-vs-Stage4 |
2.650400E-01 |
| Stage3-vs-Stage4 |
4.467400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80511161573804E-12 |
| Normal-vs-AfricanAmerican |
2.94110003018488E-09 |
| Normal-vs-Asian |
8.921500E-02 |
| Caucasian-vs-AfricanAmerican |
4.263200E-01 |
| Caucasian-vs-Asian |
7.632600E-01 |
| AfricanAmerican-vs-Asian |
4.766400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.5852210917019E-14 |
| Normal-vs-Female |
1.48190000270887E-08 |
| Male-vs-Female |
6.900200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.24490004363531E-09 |
| Normal-vs-Extreme_Weight |
2.1511681325137E-12 |
| Normal-vs-Obese |
1.0156997465316E-10 |
| Normal-vs-Extreme_Obese |
8.642800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.862400E-01 |
| Normal_Weight-vs-Obese |
6.631600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.917600E-01 |
| Extreme_Weight-vs-Obese |
4.985000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.190800E-01 |
| Obese-vs-Extreme_Obese |
9.151600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.643000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.37871960912162E-13 |
| Normal-vs-Age(61-80Yrs) |
2.64754884682361E-12 |
| Normal-vs-Age(81-100Yrs) |
6.41380004662295E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.291000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.310400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.147600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.395400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.069400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.628030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87772020154853E-12 |
| Normal-VS-Type2 PRCC |
5.51159118344913E-12 |
| Normal-VS-KIRP CIMP |
8.028800E-04 |
| Normal-VS-Unclassified PRCC |
2.56259999997788E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.973200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.166200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.933400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.475800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.118000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.709000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.30131494258512E-13 |
| Normal-vs-N1 |
3.95789999996232E-06 |
| Normal-vs-N2 |
4.648600E-04 |
| N0-vs-N1 |
2.077600E-01 |
| N0-vs-N2 |
8.872400E-01 |
| N1-vs-N2 |
6.900000E-01 |
|
|
